These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4634806)

  • 1. Possible adverse effect of phenoxybenzamine therapy in a patient with progressive systemic sclerosis.
    Parker LP; Hahn BH; Osterland CK
    Arthritis Rheum; 1972; 15(5):535-9. PubMed ID: 4634806
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects of stellate ganglion block on Raynaud's phenomenon associated with progressive systemic sclerosis.
    Omote K; Kawamata M; Namiki A
    Anesth Analg; 1993 Nov; 77(5):1057-60. PubMed ID: 8214705
    [No Abstract]   [Full Text] [Related]  

  • 3. Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient.
    Bruni C; Bellando-Randone S; Gargani L; Picano E; Pingitore A; Matucci-Cerinic M; Guiducci S
    Reumatismo; 2016 Sep; 68(2):109-11. PubMed ID: 27608801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe Raynaud's phenomenon with bosentan in a patient with systemic sclerosis.
    Dunne J; Dutz J; Shojania K; Ng B; van Eeden S
    Rheumatology (Oxford); 2006 Jul; 45(7):911-2. PubMed ID: 16531439
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic sclerosis: an update for clinicians.
    Herrick AL
    Br J Hosp Med (Lond); 2008 Aug; 69(8):464-70. PubMed ID: 18783099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualizing the effect of pentoxyphyllin infusion therapy on the circulation of the hand by Tc-99m DPTA scintigraphy.
    Garai I; Csiki Z; Szücs G; Varga J; Galuska L
    Clin Nucl Med; 2003 Jul; 28(7):611-2. PubMed ID: 12819427
    [No Abstract]   [Full Text] [Related]  

  • 7. [M scleroderma (with systemic progressive sclerosis) associated with clinical and biological signs of dermatomyositis and lupus erythematosus].
    Grupper C; Durepaire RM; Eisenmann D; Briche R
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(3):219-20. PubMed ID: 4642837
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of bosentan on fingertip rewarming in patients with systemic sclerosis.
    Autenrieth J; Riemekasten G; Bert C; Worm M
    J Dtsch Dermatol Ges; 2013 Apr; 11(4):356-9. PubMed ID: 23419126
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of systemic sclerosis in childhood complicated by severe digital ulcers].
    Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M
    Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic scleroderma in children].
    Plantin P; Gavanou J; Le Fur JM; Guillet G
    Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcinosis, Raynaud's phenomenom, sclerodactylia and telangiectasia in progressive systemic sclerosis. Statistical analysis of contingencies].
    Mintz G
    Gac Med Mex; 1976 Jun; 107(6):525-36. PubMed ID: 976673
    [No Abstract]   [Full Text] [Related]  

  • 13. [Digital ulcers in systemic scleroderma].
    Lok C; Mouthon L; Ségard M; Richard MA; Guillevin L
    Ann Dermatol Venereol; 2011 Nov; 138(11):762-8; quiz 761, 769. PubMed ID: 22078040
    [No Abstract]   [Full Text] [Related]  

  • 14. Digital arterial occlusion in scleroderma: is there a role for digital arterial reconstruction?
    Tomaino MM
    J Hand Surg Br; 2000 Dec; 25(6):611-3. PubMed ID: 11106531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treprostinil for the treatment of severe digital necrosis in systemic sclerosis.
    Engel G; Rockson SG
    Vasc Med; 2005 Feb; 10(1):29-32. PubMed ID: 15920997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis and digital gangrene without scleroderma.
    Barr WG; Robinson JA
    J Rheumatol; 1988; 15(5):875-7. PubMed ID: 3172105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic calcific pancreatitis, CRST syndrome and progressive systemic sclerosis.
    Greif JM; Wolff WI
    Am J Gastroenterol; 1979 Feb; 71(2):177-82. PubMed ID: 433900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketanserin in the treatment of progressive systemic sclerosis.
    Altomare GF; Pigatto PD; Polenghi MM
    Angiology; 1988 Jul; 39(7 Pt 1):583-6. PubMed ID: 3408023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon affecting the tongue of a patient with scleroderma.
    Bridges MJ; Kelly CA
    Ann Rheum Dis; 2002 May; 61(5):472. PubMed ID: 11959778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.